Uncategorized
Uncategorized · page 6
- Uncategorized
Europe Prepares for Surge in Medical Cannabis Access as Five Countries Finalise Reforms
A number of countries in Europe are currently at some stage of medical cannabis reform. These reforms are set to lay the foundation for five permanent medical cannabis markets in the region.
- Uncategorized
New York Cannabis Regulation Under Fire Amid Budget Cuts, Industry Clashes, and Product Investigations
New York State’s cannabis industry is facing renewed turmoil as budget changes, industry backlash, and a major product investigation converge to test the resilience of the troubled legal cannabis market.
- Uncategorized
Curaleaf International Secures Approval for EU’s First Handheld Liquid Inhalation Device
Curaleaf International, in Partnership with Jupiter Research, Secures EU Medical Device Certification for Europe’s First Handheld Liquid Inhalation Device
- Uncategorized
Why Entering the Business of Cannabis Awards Matters, And Why Now Is the Time to Step Forward
As the cannabis industry continues to mature across Europe and beyond, the need to recognise true excellence has never been greater. With entries now open for the Business of Cannabis Awards 2025, companies have a unique opportunity to demonstrate leadership, validate their impact, and strengthen their reputation within the sector.
- Uncategorized
Unchecked Credit is Suffocating the Cannabis Supply Chain
Accounts receivable (AR) are ballooning to unsustainable levels, and beyond a few informal “blacklisted” groups on social media, no one is talking about the financial chokehold this is putting on the supply chain.
- Uncategorized
MJ Berlin x Business of Cannabis Unveils Programme for 2025 International Cannabis Business Day
Prohibition Partners and Mary Jane Berlin are pleased to announce the full speaker line-up and agenda for the inaugural International Cannabis Business Day, taking place on Thursday, June 19, 2025, at Messe Berlin.
- Uncategorized
Denmark Legalises Medical Cannabis Permanently, but ‘Ludicrous’ Subsidy Gap Remains
Denmark has officially passed legislation which will solidify its long-running medical cannabis pilot programme as a permanent fixture of its national healthcare system in what has been described as a ‘victory for patients’.
- Uncategorized
Public Health, Pilot Projects and Politics: Mapping Adult-Use Cannabis in Europe
We have delved into some of the key data and insights set to be integrated into the new site, providing a taste of what readers can expect. For further exclusive analysis into the European cannabis market, pre-orders for data packages are available now.
- Uncategorized
The Business of Cannabis Awards 2025: Call for Entries Now Open
We are pleased to announce that entries are now open for the Business of Cannabis Awards 2025 — the leading event recognising excellence across Europe’s cannabis sector.
- Uncategorized
Full-Spectrum CBD Drug for Autism Spectrum Disorder Poised for Phase 2 Clinical Trials in the US
DeFloria, a joint venture between Charlotte’s Web Holdings and Ajna BioSciences, is advancing toward the start of its Phase 2 clinical trial for AJA001, a cannabinoid-based (FDA) botanical drug developed to treat behavioral symptoms associated with autism spectrum disorder (ASD).
- Uncategorized
How Cannabis Businesses are Using Employee Stock Ownership Plans to Avoid 280e Tax
When Maryland Gov. Wes Moore signed a law on April 22 exempting employee stock ownership plans (ESOPs) from the state’s strict five-year license-hold requirement for cannabis businesses, he opened up an exit strategy for founders.
- Uncategorized
Cannabis Rescheduling Given Fresh Hope as DEA Nominee Pledges to ‘Look at Science and Listen to Experts’
Cannabis rescheduling was thrown back into the spotlight last week as the new potential head of the Drug Enforcement Administration (DEA) said it would be a ‘priority’.
